MedTrace Logo

Portal Vein Pulsatility Index to Assess Fluid Intolerance

NCT06440772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-08-27

No results posted yet for this study

Summary

This study uses the portal vein pulsatility index (PVPI) to assess fluid intolerance amongst fluid responders.

Conditions

  • Venous Congestion

Interventions

DRUG

Ringer's Lactate Crystalloid Solutions

7 ml/kg ml of Ringer's Lactate is given in 10 min amongst initially tolerant fluid responders.

Sponsors & Collaborators

  • Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu

    lead OTHER

Principal Investigators

  • Cosmin Balan, PhD · "Prof CC Iliescu" Emergency Institue for Cardiovascular Diseases

  • Serban-Ion Bubenek-Turconi, Professor · "Prof CC Iliescu" Emergency Institue for Cardiovascular Diseases

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06440772 on ClinicalTrials.gov